Targeted prostate cancer screening in men with mutations in <i>BRCA1</i> and <i>BRCA2</i> detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita Mitra, Alison Falconer, Christopher S. Foster et al.|British Journal of Urology|2010Cited by 98
A Role for Common Genomic Variants in the Assessment of Familial Breast CancerSarah Sawyer, Paul A. James, Gillian Mitchell et al.|Journal of Clinical Oncology|2012Cited by 90